Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $192M | $215M | $232M | $254M | $245M | $257M | $267M | $279M | $292M | $304M |
| Revenue growth | — | 11.9% | 7.8% | 9.7% | -3.7% | 4.9% | 3.9% | 4.6% | 4.5% | 4.3% |
| Operating income | $7.17M | $9.41M | $15.5M | $14.7M | $15.8M | $8.05M | $12.4M | $16.0M | $21.3M | $20.2M |
| Operating margin | 3.7% | 4.4% | 6.7% | 5.8% | 6.5% | 3.1% | 4.7% | 5.7% | 7.3% | 6.7% |
| Net income | $3.75M | $10.0M | $32.2M | $15.8M | $14.1M | $5.84M | $12.1M | $15.2M | $20.0M | $18.3M |
| Net margin | 2.0% | 4.7% | 13.9% | 6.2% | 5.8% | 2.3% | 4.5% | 5.5% | 6.9% | 6.0% |
| EPS (diluted) | $0.12 | $0.31 | $1.00 | $0.49 | $0.44 | $0.18 | $0.39 | $0.50 | $0.66 | $0.61 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $24.2M | $46.7M | $43.2M | $65.7M | $35.9M | $42.4M | $51.2M | $64.0M | $57.7M | $63.3M |
| Capital expenditures | $4.81M | $5.51M | $7.17M | $22.0M | $1.99M | $3.42M | $1.77M | $2.20M | $1.40M | $3.69M |
| Free cash flow | $19.4M | $41.2M | $36.1M | $43.7M | $33.9M | $39.0M | $49.4M | $61.8M | $56.3M | $59.6M |
| Share buybacks | — | — | — | $0.00 | $20.0M | $5.01M | $23.1M | $8.93M | $0.00 | $30.0M |
| Dividends paid | — | — | $32.4M | $58.0K | $40.0K | $19.0K | $0.00 | $3.06M | $3.40M | $3.73M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $49.6M | $84.8M | $134M | $132M | $36.6M | $46.9M | $46.0M | $40.3M | $59.5M | $36.2M |
| Total assets | $396M | $411M | $442M | $490M | $500M | $487M | $498M | $500M | $511M | $520M |
| Shareholders' equity | $286M | $300M | $319M | $338M | $334M | $339M | $334M | $341M | $359M | $354M |
| Retained earnings | $5.35M | $17.5M | $32.4M | $48.1M | $62.3M | $68.1M | $80.2M | $92.4M | $109M | $124M |
| Shares (wtd avg diluted) | 32.1M | 32.2M | 32.3M | 32.4M | 32.0M | 31.6M | 30.7M | 30.7M | 30.5M | 30.1M |
Every figure is extracted from HEALTHSTREAM INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.